Browsing by Author Collins, Marnie

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2012All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)Bradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Catalano, Alberto; Collins, Marnie; Dilulio, J.; et al, various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Tiley, Campbell; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineAll-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4), Blood, vol.120, 8, 2012,pp 1570-1580
2017Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA eraIland, Harry; Appelbaum, Frederick; Collins, Marnie; Devlin, Sean; Douer, Dan; et al, Various; Goldman, Debra; Lee, Ju-Whei; Litzow, Mark; Mantha, Simon; Stein, Eytan; Zannino, Diana; Central Clinical School: MedicineDeterminants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era, Blood, vol.129, 13, 2017,pp 1763-1767
2014A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemiaBradstock, Kenneth; Collins, Marnie; Cull, Gavin; Di Iulio, Juliana L.; Enno, Arno; Hahn, U; Lewis, Ian D.; Link, Emma; Marlton, P.; Schwarer, Anthony; Seymour, John F.; Szer, Jeff; Western Clinical School: Westmead Millennium InstituteA randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia, British Journal of Haematology, vol.167, 5, 2014,pp 618-625
2015Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trialBradstock, Kenneth; Hertzberg, Mark; Iland, Harry; Browett, Peter; Campbell, Lynda J.; Catalano, Alberto; Collins, Marnie; Di Iulio, Juliana L.; et al, Various; Firkin, Frank; Grigg, Andrew P.; Hugman, Amanda; Reynolds, John; Supple, Shane; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Central Clinical School: MedicineUse of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial, The Lancet Haematology, vol.2, 9, 2015,pp e357-e366
2014Weight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair studyMakovey, Joanna; Berkovic, Samuel F.; Collins, Marnie; Hill, Keith D.; Kantor, Susan; Lawrence, Kate M.; O'Brien, T J; Petty, Sandra J.; Sambrook, P; Wark, J D; Northern Clinical School: MedicineWeight and fat distribution in patients taking valproate: a valproate-discordant gender-matched twin and sibling pair study, Epilepsia, vol.55, 10, 2014,pp 1551-1557